Pfizer Clinical Research Unit
- Address
- lock Available on a paid plan
Cardiovascular Diseases
The Pfizer Clinical Research Unit in Brussels conducts studies focused on heart failure and hypertension, aiming to evaluate new treatments that improve cardiac function and blood pressure control.
- Heart Failure
- Primary and secondary hypertension
- Transthyretin amyloidosis (cardiac involvement)
- Cardiovascular safety assessments
These trials seek to advance therapeutic options for patients with cardiovascular conditions and reduce disease burden.
Neoplasms
Research at the site includes ER+/HER2 negative breast cancer, small cell lung cancer, and castration-resistant prostate cancer, testing innovative therapies to halt tumor growth.
- Breast Cancer
- Small Cell Lung Cancer
- Castration‑Resistant Prostate Cancer
- Follicular Lymphoma
- Transthyretin amyloidosis
The aim is to improve survival rates and quality of life for patients with various malignancies.
Immune System Diseases
Studies target rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease, evaluating novel immunomodulators that reduce disease activity.
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Inflammatory Bowel Disease
- Ulcerative Colitis
- Immune‑mediated inflammatory disorders
These investigations aim to provide more effective and safer treatment options for autoimmune conditions.
Virus Diseases
Ongoing research on COVID‑19 and Respiratory Syncytial Virus (RSV) explores antiviral agents and vaccine strategies to prevent infection and improve outcomes.
- COVID‑19 (SARS‑CoV‑2)
- Respiratory Syncytial Virus (RSV)
- Severe acute respiratory syndrome coronavirus 2
- Antiviral drug evaluations
The goal is to enhance public health defenses against emerging and seasonal viral threats.
Nutritional and Metabolic Diseases
Trials address type 2 diabetes and obesity, testing new metabolic therapies and lifestyle interventions to improve glycemic control and weight management.
- Type 2 Diabetes Mellitus
- Obesity
- Overweight management
- Metabolic syndrome
These studies aim to reduce the long‑term complications associated with metabolic disorders.
Musculoskeletal Diseases
Research includes investigations into growth hormone deficiency and related skeletal conditions, seeking therapies that support bone health and normal growth.
- Growth Hormone Deficiency
- Musculoskeletal disorders
- Bone density abnormalities
- Hormonal regulation studies
The purpose is to develop safe and effective treatments that improve musculoskeletal function and quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Pfizer Inc.4active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Pfizer Inc.27trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pfizer Clinical Research Unit
lock Showing 1 of 27 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Bioequivalence and Safety Study of Free Acid Tafamidis 61 mg Capsule and Tablet in Healthy Adults Under Fed Conditions for the Treatment of Transthyretin Amyloidosis | Pfizer Inc. | Phase I | Not Recruiting | Mar 2026 | Jun 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Etrasimod Arginine | 1 | Unknown | 2025-07-18 | 2025-07-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.